ArticleJournal of oncology practice2016
Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.
Article in Journal of oncology practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03780491 (Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care), which is not on this map. Cited by 42 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Understanding and Addressing Patient and Provider Preferences Around Discussions of Cost of Breast Cancer Care
Who cites it
42 citing papers in PubMed.
- Economic information in clinical decision-making: focus group discussions with Finnish general practitioners and patients.BMJ open · 2026Article
- Financial toxicity in patients with newly diagnosed hepatocellular carcinoma: a cross-sectional study.Journal of gastrointestinal oncology · 2025Article
- Understanding cancer survivor cost communication experiences and preferences.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences.Journal of general internal medicine · 2025Article
- Patient Experiences and Preferences Regarding Medication Cost Discussions Among Heart Failure Patients in Singapore: A Qualitative Survey.Patient preference and adherence · 2025Article
- Catastrophic health expenditures, insurance churn, and non-employment among women with breast cancer.JNCI cancer spectrum · 2024Article
- Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity.Current atherosclerosis reports · 2023Review
- Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions.Current hematologic malignancy reports · 2023Review
- Implementation of an educational intervention to improve medical student cost awareness: a prospective cohort study.BMC medical education · 2023Article
- The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication.PEC innovation · 2022Article
- Article
- Navigating financial toxicity in patients with cancer: A multidisciplinary management approach.CA: a cancer journal for clinicians · 2022Review
- Individualized Out-of-Pocket Price Estimators for "Shoppable" Surgical Procedures: A Nationwide Cross-Sectional Study of US Hospitals.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2022Article
- Article
- What Oncologists Must Account for: The Financial Burden of Cancer-Associated Symptom Relief.JCO oncology practice · 2022Article
- Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia.PloS one · 2022Article
- How Do You DISCO? Leveraging the Discussions of Cost App to Reduce Financial Toxicity and Improve Treatment Cost Communication.Oncology issues · 2022Article
- Current Attitudes toward Unfunded Cancer Therapies among Canadian Medical Oncologists.Current oncology (Toronto, Ont.) · 2021Article
- Article
- Financial worry and psychological distress among cancer survivors in the United States, 2013-2018.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeWe surveyed US cancer doctors to examine current attitudes toward cost discussions and how they influence decision making and practice management.
methodsWe conducted a self-administered, anonymous, electronic survey of randomly selected physician ASCO members to evaluate the frequency and nature of cost discussions reported by physicians, attitudes toward discussions of cost in clinics, and potential barriers.
resultsA total of 333 of 2,290 physicians responded (response rate [RR], 15%; adjusted RR after omitting nonpracticing physician ASCO members, 25%), Respondent practice settings were 45% academic and 55% community/private practice. Overall, 60% reported addressing costs frequently/always in clinic, whereas 40% addressed costs rarely/never. The largest reported barrier was lack of resources to guide discussions. Those who reported frequent discussions were significantly more likely to prioritize treatments in terms of cost and believed doctors should explain patient and societal costs. A total of 36%did not believe that doctors should discuss costs with patients. Academic practitioners were significantly less likely to discuss costs (odds ratio [OR], 0.41; P = .001) and felt less prepared for such discussions (OR, 0.492; P = .005) but were more likely to consider costs to the patient (OR, 2.68; P = .02) and society (OR, 1.822; P = .02).
conclusionAlthough the majority of respondents believe it is important to consider out-of-pocket costs to patients, a substantial proportion do not discuss or consider costs of cancer care. Lack of consensus on the importance of such discussions and uncertainty regarding the optimal timing and content appear to be barriers to addressing costs of care with patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.